IP Library Granted Patent US 12,161,721
Granted Patent B2
US 12,161,721 · App. 17/806,107 · Granted Dec 10, 2024

Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein

Inventors: Patrick McHugh (Pipersville, PA); Michael Albert Winters (Doylestown, PA); Janelle Konietzko (Lansdale, PA)
Assignee: Merck Sharp & Dohme LLC
A61K47/549A61K47/62C07H1/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,161,721
App. No.
17/806,107
Granted
Dec 10, 2024
Kind
B2
Abstract

The present invention provides a number of process improvements related to the conjugation of capsular polysaccharides from Streptococcus pneumoniae to a carrier protein. These process are serotype specific and include acid hydrolysis, addition of sodium chloride to the reductive amination reaction, and addition of sucrose to dissolve polysaccharides. Polysaccharide-protein conjugates prepared using the processes of the invention can be included in multivalent pneumococcal conjugate vaccines.

Claims (7)

1. A method for preparing a Streptococcus pneumoniae ( S. pneumoniae ) polysaccharide-protein conjugate wherein the polysaccharide is a 15A, 16F, 17F, 20, 24F and a 35B polysaccharide and the protein is CRM197, the method comprising providing the polysaccharide within a first solution to react with the protein within a second solution to form a third solution in which a polysaccharide-protein conjugation reaction takes place to form the polysaccharide-protein conjugate, wherein the third solution contains an aprotic solvent and comprises 10 mM to 100 mM sodium chloride.

2. The method of claim 1 , wherein the concentration of sodium chloride in the third solution is from 25 to 100 mM.

3. The method of claim 1 , wherein the salt sodium chloride is present in the first solution.

4. The method of claim 1 , wherein the salt sodium chloride is present in the second solution comprising the protein.

5. The method of claim 1 , wherein the first solution and second solution are the same.

6. The method of claim 1 , wherein the aprotic solvent is DMSO.

7. The method of claim 1 , wherein the conjugation reaction is a Schiff base reduction or reductive amination.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2022
From: MCHUGH, PATRICK; WINTERS, MICHAEL ALBERT; KONIETZKO, JANELLE
To: MERCK SHARP & DOHME CORP.
Reel/Frame 060158/0744 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2022
From: MCHUGH, PATRICK; WINTERS, MICHAEL ALBERT; KONIETZKO, JANELLE
To: MERCK SHARP & DOHME CORP.
Reel/Frame 060159/0754 →
MERGER Recorded Jun 10, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 060159/0899 →
Continuity (3)
Division 16645096
Provisional Application 62555485 · Sep 7, 2017
Related Publication 20220296723A1 · Sep 22, 2022